
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Beta-Glucan
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Concentra Educación e Investigación Biomédica
Deal Size : Inapplicable
Deal Type : Inapplicable
Beta-glucans for Hospitalised Patients With COVID-19
Details : Beta-Glucan is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 20, 2022
Lead Product(s) : Beta-Glucan
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Concentra Educación e Investigación Biomédica
Deal Size : Inapplicable
Deal Type : Inapplicable
